Cite
HARVARD Citation
Frappaz, D. et al. (n.d.). OS4.1 MEVITEM: A European, randomized, open-label, Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog (SHH) pathway. Neuro-oncology. p. iii10. [Online].